The dimerization interface of EGFRvIII, whether in the context of a homodimer with a partner EGFRvIII or as a heterodimer with wild-type (over-expressed) EGFR, is a possible site of a tumor-specific epitope. The gene discussed is EGFR; the disease is neoplasm.